Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line

Updated 06/21/2024

Status Completed

Clinical Trial Summary

Evaluation of intravenous Topotecan + Cisplatin as a potential new standard of care in 1st line Small Cell Lung Cancer

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00320359
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 3
Start date	August 2002
Completion date	February 2007

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00046111` - A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors	Phase 1
	Enrolling by invitation	`NCT06293833` - Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan	N/A
	Completed	`NCT00259935` - A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors	Phase 1
	Completed	`NCT01037023` - Regulatory Hycamtin(Oral) PMS	N/A
	Active, not recruiting	`NCT04986670` - NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer	N/A
	Completed	`NCT00997061` - SCOT Registry: Small Cell Lung Cancer Treatment and Outcome	N/A
	Completed	`NCT00276276` - Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer	Phase 3
	Not yet recruiting	`NCT05320458` - Pulmonary Rehabılıtatıon Wıth Non-Small Lung Cancer	N/A
	Active, not recruiting	`NCT05228496` - A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC	Phase 2
	Completed	`NCT00316186` - First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin	Phase 2
	Not yet recruiting	`NCT04440800` - Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment
	Completed	`NCT00698516` - Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer	Phase 2
	Terminated	`NCT03499678` - Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA
	Terminated	`NCT01313663` - A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population	Phase 2
	Active, not recruiting	`NCT04660929` - CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors	Phase 1
	Completed	`NCT00043862` - The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)	Phase 2
	Recruiting	`NCT06228326` - A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs	Phase 1
	Completed	`NCT04314895` - Trial of NanoPac Intratumoral Injection in Lung Cancer	Phase 2